Abstract
Primary aldosteronism is the most prevalent form of secondary hypertension. To explore molecular mechanisms of autonomous aldosterone secretion, we performed exome sequencing of aldosterone-producing adenomas (APAs). We identified somatic hotspot mutations in the ATP1A1 (encoding an Na+/K+ ATPase α subunit) and ATP2B3 (encoding a Ca2+ ATPase) genes in three and two of the nine APAs, respectively. These ATPases are expressed in adrenal cells and control sodium, potassium and calcium ion homeostasis. Functional in vitro studies of ATP1A1 mutants showed loss of pump activity and strongly reduced affinity for potassium. Electrophysiological ex vivo studies on primary adrenal adenoma cells provided further evidence for inappropriate depolarization of cells with ATPase alterations. In a collection of 308 APAs, we found 16 (5.2%) somatic mutations in ATP1A1 and 5 (1.6%) in ATP2B3. Mutation-positive cases showed male dominance, increased plasma aldosterone concentrations and lower potassium concentrations compared with mutation-negative cases. In summary, dominant somatic alterations in two members of the ATPase gene family result in autonomous aldosterone secretion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fng.2550/MediaObjects/41588_2013_Article_BFng2550_Fig1_HTML.jpg)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fng.2550/MediaObjects/41588_2013_Article_BFng2550_Fig2_HTML.jpg)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fng.2550/MediaObjects/41588_2013_Article_BFng2550_Fig3_HTML.jpg)
![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fng.2550/MediaObjects/41588_2013_Article_BFng2550_Fig4_HTML.jpg)
Similar content being viewed by others
Accession codes
Accessions
NCBI Reference Sequence
Protein Data Bank
References
Hannemann, A. et al. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur. J. Endocrinol. 167, 7–15 (2012).
Eide, I.K., Torjesen, P.A., Drolsum, A., Babovic, A. & Lilledahl, N.P. Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J. Hypertens. 22, 2217–2226 (2004).
Rossi, G.P. et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol. 48, 2293–2300 (2006).
Choi, M. et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331, 768–772 (2011).
Boulkroun, S. et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension 59, 592–598 (2012).
Beuschlein, F. et al. Clonal composition of human adrenocortical neoplasms. Cancer Res. 54, 4927–4932 (1994).
Gicquel, C. et al. Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin. Endocrinol. 40, 465–477 (1994).
Mulatero, P. et al. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 59, 235–240 (2012).
Morth, J.P. et al. Crystal structure of the sodium-potassium pump. Nature 450, 1043–1049 (2007).
Kaplan, J.H. Biochemistry of Na,K-ATPase. Annu. Rev. Biochem. 71, 511–535 (2002).
Einholm, A.P., Andersen, J.P. & Vilsen, B. Importance of Leu99 in transmembrane segment M1 of the Na+,K+-ATPase in the binding and occlusion of K+. J. Biol. Chem. 282, 23854–23866 (2007).
Yingst, D.R., Davis, J., Krenz, S. & Schiebinger, R.J. Insights into the mechanism by which inhibition of Na,K-ATPase stimulates aldosterone production. Metabolism 48, 1167–1171 (1999).
Neri, G. et al. Ouabain chronic infusion enhances the growth and steroidogenic capacity of rat adrenal zona glomerulosa: the possible involvement of the endothelin system. Int. J. Mol. Med. 18, 315–319 (2006).
Hajnóczky, G. et al. Angiotensin-II inhibits Na+/K+ pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production. Endocrinology 130, 1637–1644 (1992).
Moseley, A.E. et al. Genetic profiling reveals global changes in multiple biological pathways in the hearts of Na,K-ATPase α1 isoform haploinsufficient mice. Cell Physiol. Biochem. 15, 145–158 (2005).
Di Leva, F., Domi, T., Fedrizzi, L., Lim, D. & Carafoli, E. The plasma membrane Ca2+ ATPase of animal cells: structure, function and regulation. Arch. Biochem. Biophys. 476, 65–74 (2008).
Street, V.A., McKee-Johnson, J.W., Fonseca, R.C., Tempel, B.L. & Noben-Trauth, K. Mutations in a plasma membrane Ca2+-ATPase gene cause deafness in deafwaddler mice. Nat. Genet. 19, 390–394 (1998).
Schultz, J.M. et al. Modification of human hearing loss by plasma-membrane calcium pump PMCA2. N. Engl. J. Med. 352, 1557–1564 (2005).
Åkerström, T. et al. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS ONE 7, e41926 (2012).
Azizan, E.A. et al. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa– and zona fasciculata–like tumors. J. Clin. Endocrinol. Metab. 97, E819–E829 (2012).
Ehret, G.B. et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109 (2011).
Spät, A. & Hunyady, L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol. Rev. 84, 489–539 (2004).
Acknowledgements
Munich and Regensburg. This work has been made possible by a grant of the Else Kröner–Fresenius-Stiftung in support of the German Conn's Registry-Else-Kröner Hyperaldosteronism Registry (to M.R.). Additional funding was received from the Deutsche Forschungsgemeinschaft to F.B. and M.R. (Re 752/17-1) and R.W. (FOR1086). The work was also supported by the German Ministry of Education and Research (01GR0802 and 01GM0867), the European Commission's Seventh Framework Programme (261123, GEUVADIS) and the DZHK.
Paris. We thank H. Lefèbvre and E. Louiset (INSERM U982 and University Hospital of Rouen) and M. Sibony (Assistance Publique–Hôpitaux de Paris, Hôpital Cochin) for providing control adrenal samples. We thank the COMETE (COrtico et MEdullo-surrénale: les Tumeurs Endocrines) network for providing tissue samples from individuals with APA. This work was funded through institutional support from INSERM and by the Agence Nationale pour la Recherche (ANR Physio 2007, 013-01; Genopat 2008, 08-GENO-021), the Fondation pour la Recherche sur l'Hypertension Artérielle (AO 2007), the Fondation pour la Recherche Médicale (ING20101221177), the Programme Hospitalier de Recherche Clinique (PHRC grant AOM 06179) and by grants from INSERM and the Ministère Délégué à la Recherche et des Nouvelles Technologies.
Aarhus. This work was supported in part by grants to B.V. from the Danish Medical Research Council, the Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Legat) and the Lundbeck Foundation.
Turin. This study was supported by grants from the Fondi Ricerca Ex-60% MIUR (Ministry of University, Scientific and Technological Research) 2012 and the Compagnia di San Paolo.
Author information
Authors and Affiliations
Contributions
S.B., H.N.N., U.D.L., D.P., V.R.S., A.W., P.T., S.D. and B.S.-C. performed the experiments. A.O., T.W., L.A., E.F., T.S., T.M.S., E.G. and A.B. performed statistical analysis and analyzed the data. B.A., M.Q., F.F., P.-F.P., F.M. and P.M. contributed materials. F.B., T.M., X.J., R.W., B.V., M.-C.Z., T.M.S. and M.R. jointly supervised research, conceived and designed the experiments, analyzed the data, contributed reagents, materials and/or analysis tools and wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1 and 2 and Supplementary Tables 1–5 (PDF 349 kb)
Rights and permissions
About this article
Cite this article
Beuschlein, F., Boulkroun, S., Osswald, A. et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45, 440–444 (2013). https://doi.org/10.1038/ng.2550
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2550
This article is cited by
-
KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma
Hypertension Research (2023)
-
CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity
Hypertension Research (2023)
-
Primary aldosteronism: molecular medicine meets public health
Nature Reviews Nephrology (2023)
-
Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism
Nature Genetics (2023)
-
Identifying primary aldosteronism patients who require adrenal venous sampling: a multi-center study
Scientific Reports (2023)